Copenhagen
Denmark
11
2023-08-03
10
2025-12-16
These are the the leading inventors for applications assigned to IO Biotech ApS:
IO Biotech ApS based in Copenhagen, DK has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
VACCINE COMPOSITIONS COMPRISING C-C MOTIF CHEMOKINE 22 (CCL22) OR FRAGMENTS THEREOF
#2 | 2023-07-27 ā Patent 12,233,103 granted on 2025-02-25Indoleamine 2,3-dioxygenase based immunotherapy
#3 | 2023-07-20 ā Patent 12,215,135 granted on 2025-02-04PDL2 compounds
#4 | 2022-11-24 ā Patent 12,187,782 granted on 2025-01-07PDL1 peptides for use in cancer vaccines
#5 | 2022-08-11 ā Patent 11,648,302 granted on 2023-05-16Indoleamine 2,3-dioxygenase based immunotherapy
#6 | 2022-02-03 ā Patent 12,194,081 granted on 2025-01-14ARGINASE1 polypeptides
#7 | 2021-12-30 ā Patent 12,234,288 granted on 2025-02-25Immunogenic arginase 2 polypeptides
#8 | 2020-12-17 ā Patent 11,447,537 granted on 2022-09-20PDL2 compounds
#9 | 2020-10-29PDL1 PEPTIDES FOR USE IN CANCER VACCINES
#10 | 2019-07-04 ā Patent 11,324,813 granted on 2022-05-10Indoleamine 2,3-dioxygenase based immunotherapy
#11 | 2019-01-10 ā Patent 11,298,413 granted on 2022-04-12Vaccine compositions comprising CāC motif chemokine 22 (CCL22) or fragments thereof
Also check out IO Biotech ApS's (Copenhagen, Denmark) applicant profile with 13 patent applications submitted.
164679 ā